Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
about
Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptorsStructure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the DrawbacksChronic caffeine administration exacerbates renovascular, but not genetic, hypertension in ratsRole of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptorsA binding site model and structure-activity relationships for the rat A3 adenosine receptorAcute but not chronic caffeine impairs functional responses to ischaemia-reperfusion in rat isolated perfused heart.Basal levels of adenosine modulate mGluR5 on rat hippocampal astrocytes.Endogenous adenosine and hemorrhagic shock: effects of caffeine administration or caffeine withdrawalIdentification of an adenosine receptor domain specifically involved in binding of 5'-substituted adenosine agonists.Investigation of the role of intracellular Ca(2+) stores in generation of the muscarinic agonist-induced slow afterdepolarization (sADP) in guinea-pig olfactory cortical neurones in vitro.1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junctionAdenosine A1 and A2 receptors: structure--function relationshipsEffect of adenosine and adenosine analogues on cyclic AMP accumulation in cultured mesangial cells and isolated glomeruli of the rat.Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.Safety considerations for patients with epilepsy taking antiepileptic drugs alongside caffeine or other methylxanthine derivatives.Thapsigargin-induced Ca2+ increase inhibits TGFβ1-mediated Smad2 transcriptional responses via Ca2+/calmodulin-dependent protein kinase II.Xanthine interference with dipyridamole-thallium-201 myocardial imaging.Systemic administration of rolipram increases medullary and spinal cAMP and activates a latent respiratory motor pathway after high cervical spinal cord injury.Effect of tienoxolol, a new diuretic beta-blocking agent, on urinary prostaglandin excretion in the rat.Adenosine receptor-mediated contraction and relaxation of guinea-pig isolated tracheal smooth muscle: effects of adenosine antagonistsTwo saturable recognition sites for (-) [125I]iodo-N6-(4-hydroxyphenyl-isopropyl)-adenosine binding on purified cardiac sarcolemma.Caffeine affects autonomic control of heart rate and blood pressure recovery after aerobic exercise in young adults: a crossover study.The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.The effects of vasoactive intestinal peptide (VIP) antagonists, and VIP and peptide histidine isoleucine antisera on non-adrenergic, non-cholinergic relaxations of tracheal smooth muscle.Influence of different methylxanthines on the anticonvulsant action of common antiepileptic drugs in mice.Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests.Synthesis, pharmacological activity and nitric oxide generation by nitrate derivatives of theophylline.Collision-induced dissociation studies of caffeine in positive electrospray ionisation mass spectrometry using six deuterated isotopomers and one N1-ethylated homologue.Evidence for the presence of both P1 and P2 purinoceptors in the rat myometrium.Comparison of phosphodiesterase inhibitors of differing isoenzyme selectivity added to St. Thomas' hospital cardioplegic solution used for hypothermic preservation of rat lungs.Xanthine scaffold: scope and potential in drug development
P2860
Q24599034-B27FEC96-5ABE-4A9D-8291-5F82EFBCCDD1Q26740559-19943E6F-CFEC-455F-8742-BF7132159924Q28360444-12518FB6-DAA0-4CBA-A867-5C80D5ACDA28Q28369018-AE3D3C6E-A1E6-4A3B-B744-F3B606A32728Q28369257-FBA7067E-A8A4-4620-81DE-1222242EF657Q31818100-9C89490E-9FEB-4C1F-AC38-FF764472B21BQ31911336-58551F5A-E514-404E-BD3E-C8C7EC0DBBB1Q33582693-7334D836-BE86-4F55-8385-7FAEEE56C94FQ33796897-1D225404-3C63-4173-A7EF-9BB919779E6AQ35042125-298C1A75-7554-4D37-B182-31131C602ADFQ35756157-5F4EB1CA-50F5-45E2-957B-4819897CFFA4Q35766866-C216C11E-C6DB-4EB5-990F-BE01CDAE9139Q35871247-D9F9BC1A-DA48-4747-980A-00BC872E0891Q36332205-3D37B91D-7CC0-42C1-8626-2230C8390DA7Q38213495-B5CE7184-3F83-46CB-9EBE-83ED122FBFB1Q39666375-D5FFC625-ED4E-4C94-86F5-C88167EC9832Q40459007-1EDB6DC1-AA79-4750-B1F8-C5AD51B737C1Q41968957-6136A9ED-8BCF-4622-B0CE-2B6F957466CAQ42016607-D662BDBE-1B63-4773-9EEF-BB4444F892B9Q42201162-4C166CA4-F6FC-4D0C-8063-7AE2EDA892FEQ42223575-2B5681B9-2202-40E7-ACD2-E37595721C49Q42620976-C8E6E9BF-2783-458F-B4A0-F69DAB608029Q42847770-F7B89EC7-7F04-49B1-9517-8EDB7B1D25CEQ42848159-03B0A546-E5D8-4C59-998D-05E7EB58FCAAQ44369685-D18ECCB5-3217-4604-A6EE-9140FA7A9661Q45129880-79E2E81B-768C-4243-B498-89D8C78B916DQ46641313-319D1512-95EB-4C7A-AFC7-12BE4A8184CDQ46917367-33039BE9-222D-4522-8338-B877A6F96F8CQ47804903-070C9DBF-EB42-43B4-95FC-95A7DFD13F2FQ54036842-B90FB11B-2ED4-4BAD-B166-3A185974078AQ57298107-9BD9EA31-BDDB-45D6-92CF-D3F9BDA8D38B
P2860
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
description
1985 nî lūn-bûn
@nan
1985 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
@ast
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
@en
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
@nl
type
label
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
@ast
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
@en
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
@nl
prefLabel
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
@ast
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
@en
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
@nl
P2093
P356
P1476
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
@en
P2093
P2888
P304
P356
10.1007/BF00572436
P577
1985-09-01T00:00:00Z
P6179
1023414015